Scholarlink

Background <p>The present study aimed to survey the antibiotic resistance patterns and toxin gene expression levels in different PCR ribotypes and sequency types of <i>C.difficile</i> isolated from patients with colorectal polyps.</p> Methods <p>A total of 305 stool specimens were collected from patients with colorectal polyps. The antimicrobial susceptibility of <i>C. difficile</i> isolates was determined using the Liofilchem<sup>®</sup> MIC Test Strips and disk diffusion method (DDM). The prevalence of toxin-encoding genes (<i>tcdA</i>, <i>tcdB</i>, <i>cdtA</i>, <i>cdtB</i>) was determined by PCR assay. PCR ribotyping was performed on all <i>C. difficile</i> isolates that tested positive for at least one of the toxin-encoding genes. SYBR Green based qRT-PCR was employed to determine the relative expression of toxin-encoding genes in <i>C. difficile</i> Ribotypes (RTs). Multilocus sequence typing (MLST) analysis was performed to investigate the genetic relationships of the <i>C. difficile</i> RTs.</p> Results <p>A total of 37 <i>C. difficile</i> isolates were isolated from 305 stool samples (12.1%). Overall, 35.1% (<i>n</i> = 13/37), 48.6% (<i>n</i> = 18/37), 35.1% (<i>n</i> = 13/37), and 43.2% (<i>n</i> = 16/37) of <i>C. difficile</i> isolates were positive for <i>tcdA</i>, <i>tcdB</i>, <i>cdtA</i>, and <i>cdtB</i> genes, respectively. Out of 23 toxin gene-positive <i>C. difficile</i> isolates, 8 isolates were <i>tcdA</i>-/<i>tcdB</i>+/<i>cdtA</i>+/<i>cdtB</i>+, 5 isolates were <i>tcdA</i>+/<i>tcdB</i>+/<i>cdtA</i>+/<i>cdtB</i>-, and 4 isolates were <i>tcdA</i>+/<i>tcdB</i>-/<i>cdtA</i>-/<i>cdtB</i>+. The most prevalent RTs among <i>C. difficile</i> isolates were 012 (34.78%; <i>n</i> = 8), 126 (21.73%; <i>n</i> = 5), and 001 (17.39%; <i>n</i> = 4). The most frquenctly detected sequence types were ST-2 (<i>n</i> = 9; 39.13%), followed by ST-54 (<i>n</i> = 6; 26%). Toxigenic <i>C. difficile</i> isolates showed the lowest resistance rate to vancomycin (8.7%; <i>n</i> = 2/23) and metronidazole (13%; <i>n</i> = 3/20), respectively. The rates of vancomycin resistance in RT001 (25%) and RT126 (20%) <i>C. difficile</i> isolates were higher than those in other RTs. <i>tcdB</i> gene expression was significantly high in RT027 (8.15 fold), and RT078 (6.25 fold). Meanwhile, the <i>tcdA</i> relative expression level was significantly high in RT027 (6.25 fold), RT078 (4.75 fold) and RT126 (4.35 fold).</p> Conclusion <p>The significant increase in toxin gene expression observed in RT012, in addition to the hypervirulent ribotypes RT027 and RT078, is particularly concerning and highlights the potential for RT012 to become an emerging clinical challenge.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Antibiotic resistance profiles and molecular characteristics of Clostridioides difficile PCR ribotypes in patients with colorectal polyps

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月31日

查看全文
  • Taher Azimi,
  • Maryam Asli,
  • Ebrahim Fallahzadeh,
  • Mina Biglari Nejad,
  • Sahar Sabour,
  • Neda Mohagheghzadeh,
  • Saeed Soleiman Meigooni,
  • Shiva Nazari

摘要

Background

The present study aimed to survey the antibiotic resistance patterns and toxin gene expression levels in different PCR ribotypes and sequency types of C.difficile isolated from patients with colorectal polyps.

Methods

A total of 305 stool specimens were collected from patients with colorectal polyps. The antimicrobial susceptibility of C. difficile isolates was determined using the Liofilchem® MIC Test Strips and disk diffusion method (DDM). The prevalence of toxin-encoding genes (tcdA, tcdB, cdtA, cdtB) was determined by PCR assay. PCR ribotyping was performed on all C. difficile isolates that tested positive for at least one of the toxin-encoding genes. SYBR Green based qRT-PCR was employed to determine the relative expression of toxin-encoding genes in C. difficile Ribotypes (RTs). Multilocus sequence typing (MLST) analysis was performed to investigate the genetic relationships of the C. difficile RTs.

Results

A total of 37 C. difficile isolates were isolated from 305 stool samples (12.1%). Overall, 35.1% (n = 13/37), 48.6% (n = 18/37), 35.1% (n = 13/37), and 43.2% (n = 16/37) of C. difficile isolates were positive for tcdA, tcdB, cdtA, and cdtB genes, respectively. Out of 23 toxin gene-positive C. difficile isolates, 8 isolates were tcdA-/tcdB+/cdtA+/cdtB+, 5 isolates were tcdA+/tcdB+/cdtA+/cdtB-, and 4 isolates were tcdA+/tcdB-/cdtA-/cdtB+. The most prevalent RTs among C. difficile isolates were 012 (34.78%; n = 8), 126 (21.73%; n = 5), and 001 (17.39%; n = 4). The most frquenctly detected sequence types were ST-2 (n = 9; 39.13%), followed by ST-54 (n = 6; 26%). Toxigenic C. difficile isolates showed the lowest resistance rate to vancomycin (8.7%; n = 2/23) and metronidazole (13%; n = 3/20), respectively. The rates of vancomycin resistance in RT001 (25%) and RT126 (20%) C. difficile isolates were higher than those in other RTs. tcdB gene expression was significantly high in RT027 (8.15 fold), and RT078 (6.25 fold). Meanwhile, the tcdA relative expression level was significantly high in RT027 (6.25 fold), RT078 (4.75 fold) and RT126 (4.35 fold).

Conclusion

The significant increase in toxin gene expression observed in RT012, in addition to the hypervirulent ribotypes RT027 and RT078, is particularly concerning and highlights the potential for RT012 to become an emerging clinical challenge.